A DNA vaccine against extracellular domains 1-3 of flk-1 and its immune preventive and therapeutic effects against H22 tumor cell in vivo

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

186

HTML

2052

Figures (1-8)

150

Tables (1-3)

127

Sum=2515

Jul 15, 2004 (publication date) through Apr 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jul 15, 2004; 10(14): 2039-2044
Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2039

Table 2 Therapeutic effects of DNA vaccine against H22 tumor cell in vivo (mean ± SD)

^aP < 0.05,

^cP < 0.05,

^eP < 0.05 vs plasmid group and saline group.

Citation: Lü F, Qin ZY, Yang WB, Qi YX, Li YM. A DNA vaccine against extracellular domains 1-3 of flk-1 and its immune preventive and therapeutic effects against H22 tumor cell in vivo. World J Gastroenterol 2004; 10(14): 2039-2044
URL: https://www.wjgnet.com/1007-9327/full/v10/i14/2039.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i14.2039